Global Breast Biopsy Device Market By Test Type (Open Surgical Biopsy, Needle Breast Biopsy), By Product (Biopsy Tables, Biopsy Needles, and Others), By Guidance Type (Magnetic Resonance Guided Biopsies, Mammography-Guided Stereotactic, Ultrasound-Guided), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Breast Biopsy Device Market Overview:

The market size for breast biopsy devices was USD 601.67 million in 2021 at a CAGR of 8.3%.

Global Breast Biopsy Device Market

Test Type Analysis

This industry is divided by type into open and needle surgical biopsies. The former can be further classified into fine-needle aspiration, core needle biopsy, or vacuum-assisted central biopsy.

In 2021, the market share for fine-needle extraction is expected to be the highest due to increased demand for minimally invasive procedures.

Vacuum-assisted Core Biopsy is expected to grow at an impressive CAGR value over the forecast period. This technique involves making a small incision through the skin, inserting the needle, and then taking samples using a vacuum-powered device.

Product Analysis

The industry’s most important products include needles and tables, localization cables, and guidance systems, among others. A large portion of the market was dominated by needles in 2021. This is due to its broad application in the needle breast market. Most of the advancements and enhancements can be seen in the products category.

Stryker Precise Core’s needle allows for sample acquisition with greater precision, and less tissue damage. The guidance system product segment is also expected to experience a significant growth rate over the forecast period.

Guidance Type Analysis

Guidance systems are needed to locate abnormalities in the breasts during biopsy procedures. The available guiding systems for biopsy include mammography-guided stereotactic (Ultrasound-guided), and magnetic resonance-guided biopsies. They are used to detect and locate abnormal cell growths.

The sector’s largest share is made up of the mammography-guided segment. However, false positives are possible due to the dense breast tissue image. The ultrasound-guided procedure produces more accurate results. It is expected to see the highest rate of growth during the study period.

Key Market Segments

Test Type

• Open Surgical Biopsy
• Needle Breast Biopsy

Product

• Biopsy Tables
• Biopsy Needles
• Guidance Systems
• Localization Wires

Guidance Type

• Magnetic Resonance Guided Biopsies
• Mammography-Guided Stereotactic
• Ultrasound-Guided

Market Dynamics

It involves the removal of liquid from suspicious tissue. It requires the use of a guiding device, which helps to find a lump or abnormality within the breast region.

Mammography, ultrasound, and magnetic resonance imaging are all used as guiding systems for the detection of breast cancer. Because of the growing demand for non-radiation biopsies, and the increased demand for minimally invasive procedures. The fastest segment growth is expected to be in the ultrasound segment.

The market is expected to grow due to the increase in breast cancers and the rise in awareness programs.

In addition, product enhancements will continue to be introduced in the market. These products are expected to have a positive effect on the industry over the forecast period. The Goal of C.R. Bard Truguide is disposable for the collection of tissue samples, coaxial biopsy needles with extremely thin sides offer exceptional efficiency and precision.

However, there are risks that the procedure can pose to the Breast Biopsy Device market. The degree of risk is determined by the extent of the procedure. Although surgical core procedures can be more precise and effective, there are still major risks.

Additionally, around 60% to 80% of biopsies are benign. It is important that women seek second opinions before considering any surgical procedure. This could negatively impact market growth.

Regional Analysis

The report covers North America as well as Europe, Asia Pacific, South America, and MEA. According to the market growth rate, Asia Pacific Breast Biopsy Device Market should experience the greatest growth. This growth can be attributed to the rising incidence of breast cancer among women.

North America holds the largest share of the industry’s revenue in 2021. North America is the largest market, with a share of 48%. This is due in large part to the increased awareness generated through cancer screening programs, and other supportive government initiatives.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share Analysis

Becton, C.R Bard Inc. Dickinson and Company, Devicor Medicals Products Inc., and Hologic Inc., are just a few of the major players in the Breast Biopsy Equipment Market. These companies are heavily involved in the development and implementation of strategic initiatives like joint ventures with FDA approvals, mergers, acquisitions, and mergers in order to retain their industry position.

Hologic Inc. announced that in April 2016, the FDA approved the commercially available AffirmProne biopsy system. The new product includes 2D/3D imaging and guided systems.

Key Market Players

• Becton
• C.R Bard Inc.
• Dickinson and Company
• Devicor Medicals Products Inc.
• Hologic Inc.
• Other Key Players

For the Breast Biopsy Devices Market research study, the following years have been considered to estimate the market size: